Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
about
On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon SpeciesInvasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal PathogenTriclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformansFluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine CryptococcosisPd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal EffectCandida mesorugosa sp. nov., a novel yeast species similar to Candida rugosa, isolated from a tertiary hospital in Brazil.Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species.Regulatory circuitry governing fungal development, drug resistance, and disease.A Case of Onychomycosis Caused by Rhodotorula glutinis.Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosisSurveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.Epidemiology of invasive fungal infections in the mediterranean areaMultiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.The 100-genomes strains, an S. cerevisiae resource that illuminates its natural phenotypic and genotypic variation and emergence as an opportunistic pathogen.Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal studyMisidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.Retrospective Study of Cryptococcal Meningitis With Elevated Minimum Inhibitory Concentration to Fluconazole in Immunocompromised Patients.Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Epidemiology and outcome of Rhodotorula infection in haematological patients.Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.Strategies to manage antifungal drug resistance.Uncommon yeast infections in hematological patients: from diagnosis to treatment.Fluconazole resistance in cryptococcal disease: emerging or intrinsic?Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.Invasive Trichosporon infection in solid organ transplant patients: a report of two cases identified using IGS1 ribosomal DNA sequencing and a review of the literature.Case Report of Cryptococcus Albidus Peritonitis in a Peritoneal Dialysis Patient and a Review of the Literature.Fungal model systems and the elucidation of pathogenicity determinants.Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients.Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
P2860
Q26801428-5E823497-065C-432F-A4EA-E5C48F012B7AQ28071847-30F9C037-AB6F-4F36-82C5-22F492E1A593Q28390076-1099A3F1-CD6F-4772-97AA-1E8783FE18AFQ28544939-BFB2978F-2B06-46BB-8B4C-573C282D3BE5Q28550084-62F443EB-C39F-4A51-8E60-85E7433A1E9CQ30559661-4A7E8AF7-192D-4990-9462-4E1CBF84BC88Q30834974-F1D454A6-8EB0-4D3C-A767-DD6C53E635A5Q31119810-EFD5636B-F411-455D-829B-0CD1665D9712Q33532335-A228B684-0670-47FD-A1B7-43BAFE3810E7Q33644147-F9AA5EA6-B927-44A5-9F60-96BC5A125F7BQ34190284-D4CE63C0-A55F-4D60-80E4-15AE67A6CE14Q34310909-A5A6BF8F-E39B-4207-B589-43A6EEC7E8B1Q34737783-5E1C644A-48A4-4327-8CD8-3F88B0AFBE66Q34856747-9D116C51-3A76-43BD-A2FB-81888AC2EAC8Q35010686-488AFC4F-133A-49EF-812A-10F4894577EDQ35382120-1211041D-BE38-43F4-BD2B-B30BEB800F34Q35561978-2AC3E151-6887-4409-B365-12201FEBC91DQ35700772-434674C4-40EE-4B0B-B7E5-1BD000B2054EQ35839167-7651E49B-135C-4912-85C6-80517044F2A6Q36018713-783238E1-0DEF-4CA9-885E-D222A1B6EADFQ36364064-27C6D7A5-F9DE-4F53-8DBD-44CD429081DCQ36414000-AB27EF00-314E-4ABB-88A2-8939D782856EQ36930128-DA6F352D-CFE1-469C-B7DB-986C1B0EC3F8Q37091636-C53A2FD1-1C33-4AE9-A959-72195A7063A4Q37373824-EA54348A-C66F-4FF9-ACE7-00EA91398FB5Q37546287-363C465F-8143-4EB2-891A-6FB21C6D0392Q37608276-0C8F30DF-EC24-4B02-9E2A-DFBD04F29EFBQ37718939-09401905-2B0F-4827-9B7A-D8020FBC9DD3Q37742176-DD79919A-5018-4AB6-82F5-C9753D86B3F9Q37827872-14288642-CE75-4225-B4AD-FC12D07830DBQ37949642-630C637A-6F22-4527-BED0-90BCB884A30BQ38044487-3BD68B67-BE7D-4D13-B9B3-1EA97F8689DDQ38154164-0159F013-7815-4C27-BC21-B511912257E9Q38175180-655F8C2E-B762-4089-BA2C-70D104200661Q38192481-8AE00440-0F78-4ACF-961E-D46CDB6706A9Q38228039-63300F43-A051-4141-979E-3A3AD75DBD73Q38397662-A49120AD-F264-4E1C-A6F0-91ECC26D9C9FQ38467366-CC49CD97-4893-4A40-8413-AA9B8E865294Q38610744-48986A64-0E0B-4BE7-B984-043301C554C3Q38883793-63116322-EE91-49EC-ABF9-05B47A4618AD
P2860
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Results from the ARTEMIS DISK ...... ardized disk diffusion testing
@en
Results from the ARTEMIS DISK ...... rdized disk diffusion testing.
@nl
type
label
Results from the ARTEMIS DISK ...... ardized disk diffusion testing
@en
Results from the ARTEMIS DISK ...... rdized disk diffusion testing.
@nl
prefLabel
Results from the ARTEMIS DISK ...... ardized disk diffusion testing
@en
Results from the ARTEMIS DISK ...... rdized disk diffusion testing.
@nl
P2093
P2860
P356
P1476
Results from the ARTEMIS DISK ...... ardized disk diffusion testing
@en
P2093
C Rennison
D Dzierzanowska
Global Antifungal Surveillance Group
K Muehlethaler
M A Pfaller
M Lisalova
V A Newell
P2860
P304
P356
10.1128/JCM.01747-08
P407
P577
2008-11-12T00:00:00Z